Log in to save to my catalogue

CO-evaluation of Immunhistochemical PD-L1 and FOXP3 Expressions in Breast Cancer

CO-evaluation of Immunhistochemical PD-L1 and FOXP3 Expressions in Breast Cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_eef1488e4f6e4259860efc1cf0792bd3

CO-evaluation of Immunhistochemical PD-L1 and FOXP3 Expressions in Breast Cancer

About this item

Full title

CO-evaluation of Immunhistochemical PD-L1 and FOXP3 Expressions in Breast Cancer

Publisher

Galenos Yayinevi

Journal title

Forbes Tıp Dergisi, 2023-07, Vol.4 (2), p.161-167

Language

English

Formats

Publication information

Publisher

Galenos Yayinevi

Subjects

More information

Scope and Contents

Contents

Objective: Breast cancer is the most common cancer among women and is the second most frequent cause of cancer-related deaths worldwide. The aim of this study was to determine the prognostic values of PD-L1 expression in breast cancers and to detect the presence of FOXP3-positive Treg cells in the tumor microenvironment. Methods: This study include...

Alternative Titles

Full title

CO-evaluation of Immunhistochemical PD-L1 and FOXP3 Expressions in Breast Cancer

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_eef1488e4f6e4259860efc1cf0792bd3

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_eef1488e4f6e4259860efc1cf0792bd3

Other Identifiers

E-ISSN

2757-5241

DOI

10.4274/forbes.galenos.2022.98698

How to access this item